![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Clears GenePOC’s Revogene Instrument and GBS LB Test
FDA Clears GenePOC’s Revogene Instrument and GBS LB Test
![](https://www.fdanews.com/ext/resources/test/Device_Images/microscope-yellow-background.jpg?t=1433878525&width=430)
GenePOC has received FDA clearance for its GenePOC GBS LB assay and its Revogene instrument.
The Revogene is an automated, stand-alone instrument for molecular diagnostic testing that can run up to 8 samples at a time.
The GenePOC GBS (Group B Streptococcus) LB assay detects GBS colonization from Lim Broth samples.
The instrument was released on the European market in the first quarter of 2017. — Cynthia Jessup
Upcoming Events
-
21Oct